Sorrento Therapeutics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRNE and other ETFs, options, and stocks.About SRNE
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates.
CEOHenry H. Ji
CEOHenry H. Ji
Employees799
Employees799
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1989
Founded1989
Employees799
Employees799
SRNE Key Statistics
Market cap706.42M
Market cap706.42M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume8.05M
Average volume8.05M
High today$1.65
High today$1.65
Low today$1.52
Low today$1.52
Open price$1.65
Open price$1.65
Volume6.51M
Volume6.51M
52 Week high$7.79
52 Week high$7.79
52 Week low$1.15
52 Week low$1.15
SRNE Earnings
-$0.57
-$0.30
-$0.03
$0.24
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated— per share
Estimated— per share
ActualExpected Nov 4, After Hours
ActualExpected Nov 4, After Hours